Under construction – not a live service
Sign in
Taking people in FrancePhase 1

Donor Fat-Derived Cells Tested in Primary Progressive Multiple Sclerosis

Tests donor fat-derived cells in adults with primary progressive multiple sclerosis.

Key facts

Who runs it
Centre Hospitalier Universitaire De Rennes
Where
Creteil and Rennes, FranceSee the 2 sites
Registry title
MAESTRO-4MS : "Allogenic Adipose tissue-derived Mesenchymal Stromal Cells for the treatment of Primary Progressive Multiple Sclerosis: an open-label phase I clinical trial."
Status
Recruiting
Phase
Phase 1
People taking part
15 people, planned
Started
6 Mar 2025
Expected to end
31 Dec 2030
Type of study
Interventional
Record updated
2 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18 to 64 with primary progressive multiple sclerosis. It tests stem cells taken from fat tissue of a donor.

Age
18 to 64 years
Sex
All sexes
Disease stage
Primary progressive multiple sclerosis

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

Where in France

  • Assistance Publique Hopitaux De ParisCreteil, FranceTaking people
  • Centre Hospitalier Universitaire de RennesRennes, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Donor Fat-Derived Cells Tested in Primary Progressive Multiple SclerosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Fit questions
Built from 2023-509538-20-01, who can take part
Record updated
2 July 2026